/
CAH
$238.65+$2.43 (+1.03%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$55.7B
234M shares
52-week range
$137.75 – $240.93
98% from low
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$180.71
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136.81B | $145.53B | $152.92B | $162.47B | $181.33B | $204.98B | $226.83B | $222.58B |
| Cost of revenue | $129.63B | $138.70B | $146.05B | $155.69B | $174.84B | $198.10B | $219.41B | $214.41B |
| Gross profit | $7.18B | $6.83B | $6.87B | $6.78B | $6.48B | $6.89B | $7.41B | $8.17B |
| Gross margin | 5.2% | 4.7% | 4.5% | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $126.0M | $2.06B | −$4.10B | $472.0M | −$607.0M | $752.0M | $1.24B | $2.27B |
| EBITDA | $1.13B | $3.04B | −$2.62B | $1.29B | $55.0M | $1.44B | $1.96B | $3.11B |
| Net income | $256.0M | $1.36B | −$3.69B | $611.0M | −$938.0M | $330.0M | $852.0M | $1.56B |
| Net margin | 0.2% | 0.9% | -2.4% | 0.4% | -0.5% | 0.2% | 0.4% | 0.7% |
| EPS (diluted) | 0.81 | 4.53 | -12.60 | 2.08 | -3.34 | 1.26 | 3.45 | 6.45 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $256.1B | $10.77 | $10.72–$10.80 | 10 |
| 2027 | $277.1B | $12.01 | $11.70–$12.19 | 10 |
| 2028 | $299.2B | $13.52 | $10.19–$15.79 | 5 |
| 2029 | $322.7B | $15.02 | $14.43–$15.47 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$356.51
Price
$238.65
Implied upside
+49%
Peer comparison
Cardinal Health, Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
www.cardinalhealth.com- Employees
- 57,700
- IPO / List date
- Aug 4, 1983
- HQ
- DUBLIN, OH
Held by traders on TradeandTell
No one on the platform currently holds CAH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 344,825 | $72.9M |
| Bridgewater Associatesas of 2026-03-31 | 115,229 | $24.3M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 0.86% ($2.05/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-01 | $0.5158 | 2026-07-15 |
| 2026-04-01 | $0.5107 | 2026-04-15 |
| 2026-01-02 | $0.5107 | 2026-01-15 |
| 2025-10-01 | $0.5107 | 2025-10-15 |
| 2025-07-01 | $0.5107 | 2025-07-15 |
| 2025-04-01 | $0.5056 | 2025-04-15 |
| 2025-01-02 | $0.5056 | 2025-01-15 |
| 2024-10-01 | $0.5056 | 2024-10-15 |
| 2024-07-01 | $0.5056 | 2024-07-15 |
| 2024-03-28 | $0.5006 | 2024-04-15 |
Recent trades on TradeandTell
No one on the platform has traded CAH yet.
